Samuel Koprak

Statistics

Publications

Citations

163

H-Index

Active since

1976

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Samuel Koprak is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in cell signaling, pharmacology, and calcineurin pathway inhibition.

Publications per year

1976–2003

Publications

A Specific Inhibitor of the p38 Mitogen Activated Protein Kinase Affects Differentially the Production of Various Cytokines by Activated Human T Cells: Dependence on CD28 Signaling and Preferential Inhibition of IL-10 Production

Samuel Koprak, Mary Jo Staruch, Francis J. Dumont · Cellular Immunology · 1999 · 74 citations

Life Sciences, Cell Biology, Immunology +17

A TACROLIMUS-RELATED IMMUNOSUPPRESSANT WITH REDUCED TOXICITY

Francis J. Dumont, Samuel Koprak, Mary Jo Staruch et al. · Transplantation · 1998 · 26 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Down-regulation of cell surface CXCR6 expression during T cell activation is predominantly mediated by calcineurin

Samuel Koprak, Stephen Matheravidathu, Martin S. Springer et al. · Cellular Immunology · 2003 · 23 citations

Life Sciences, Immunology, Molecular Biology +12

The conversion of an ovariectomy-nonresponsive to an ovariectomy-responsive mammary tumor strain.

Edward J. Diamond, Samuel Koprak, Samuel K. Shen et al. · PubMed · 1976 · 15 citations

Medicine, Endocrinology, Oncology +10

C32-O-imidazol-2-yl-methyl ether derivatives of the immunosuppressant ascomycin with improved therapeutic potential

Mark T. Goulet, Shelli R. McAlpine, Mary Jo Staruch et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 13 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

1–5 of 6